RIFAMPICIN

RIFAMPICIN was reported 10069 times

RIFAMPICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SERPIGINOUS CHOROIDITIS 19 0.3958
1 MYCOBACTERIUM ULCERANS INFECTION 22 0.3860
2 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 53 0.2912
3 TYPE 2 LEPRA REACTION 35 0.1872
4 NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC 9 0.1667
5 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 22 0.1549
6 TUBERCULOID LEPROSY 10 0.1538
7 DIAPHRAGMATIC INJURY 11 0.1486
8 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 46 0.1373
9 TYPE 1 LEPRA REACTION 7 0.1373
10 CYSTIC FIBROSIS PANCREATIC 6 0.1333
11 TUBERCULOSIS OF EYE 9 0.1286
12 ALVEOLAR LUNG DISEASE 22 0.1158
13 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 29 0.1070
14 LEPROMATOUS LEPROSY 9 0.1059
15 HEMIANOPIA HETERONYMOUS 9 0.1047
16 HYPOPROTHROMBINAEMIA 31 0.1030
17 MENINGITIS TUBERCULOUS 49 0.0877
18 ACID FAST BACILLI INFECTION 14 0.0870
19 IMMUNE RECONSTITUTION SYNDROME 109 0.0844
20 PARADOXICAL DRUG REACTION 295 0.0801
21 ENDOCARDITIS CANDIDA 6 0.0789
22 SPLENIC EMBOLISM 9 0.0783
23 TUBERCULOSIS OF GENITOURINARY SYSTEM 7 0.0769
24 SIDEROBLASTIC ANAEMIA 10 0.0714
25 CHOROIDITIS 25 0.0668
26 RHODOCOCCUS INFECTION 11 0.0663
27 PERICARDITIS TUBERCULOUS 6 0.0600
28 VITAMIN K DEFICIENCY 24 0.0597
29 BRUCELLOSIS 9 0.0596
30 TUBERCULOSIS GASTROINTESTINAL 19 0.0596
31 MYCOBACTERIUM KANSASII INFECTION 9 0.0549
32 JOINT TUBERCULOSIS 6 0.0536
33 CARDIAC VALVE VEGETATION 26 0.0535
34 LEPROSY 11 0.0529
35 PERITONEAL TUBERCULOSIS 23 0.0524
36 PYROGLUTAMATE INCREASED 8 0.0497
37 BONE TUBERCULOSIS 19 0.0496
38 LYMPH NODE TUBERCULOSIS 33 0.0444
39 TUBERCULOUS PLEURISY 20 0.0423
40 TUBO-OVARIAN ABSCESS 10 0.0410
41 EXTRAPULMONARY TUBERCULOSIS 12 0.0407
42 MECONIUM IN AMNIOTIC FLUID 14 0.0398
43 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 12 0.0388
44 ENDOCARDITIS STAPHYLOCOCCAL 19 0.0385
45 GRANULOMATOUS LIVER DISEASE 26 0.0369
46 VITAMIN B1 DECREASED 9 0.0359
47 DISSEMINATED TUBERCULOSIS 86 0.0335
48 BIOPSY LIVER ABNORMAL 10 0.0333
49 PULMONARY TUBERCULOSIS 142 0.0332
50 BOVINE TUBERCULOSIS 12 0.0313
51 DANDY-WALKER SYNDROME 8 0.0309
52 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 96 0.0295
53 JARISCH-HERXHEIMER REACTION 20 0.0281
54 MYCOBACTERIAL INFECTION 48 0.0278
55 TESTICULAR MASS 6 0.0274
56 RED MAN SYNDROME 24 0.0273
57 MONONUCLEOSIS SYNDROME 7 0.0272
58 METAL POISONING 15 0.0259
59 MALABSORPTION FROM ADMINISTRATION SITE 6 0.0259
60 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 31 0.0258
61 SPLENIC ABSCESS 10 0.0246
62 EOSINOPHILIC PNEUMONIA ACUTE 21 0.0242
63 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 118 0.0237
64 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 11 0.0236
65 MYCOBACTERIUM AVIUM COMPLEX INFECTION 63 0.0234
66 PLASMABLASTIC LYMPHOMA 8 0.0223
67 OPTIC NEUROPATHY 47 0.0222
68 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 558 0.0217
69 COAGULATION FACTOR V LEVEL DECREASED 7 0.0214
70 ATYPICAL MYCOBACTERIAL INFECTION 30 0.0212
71 DIFFUSE ALVEOLAR DAMAGE 23 0.0200
72 VASCULITIS CEREBRAL 9 0.0200
73 HYPERTENSIVE URGENCY 11 0.0199
74 LINEAR IGA DISEASE 33 0.0198
75 MYCOBACTERIUM ABSCESSUS INFECTION 14 0.0196
76 MARROW HYPERPLASIA 13 0.0191
77 EOSINOPHILIC PNEUMONIA 60 0.0190
78 CYTOLYTIC HEPATITIS 63 0.0190
79 COMA HEPATIC 14 0.0189
80 HEPATITIS FULMINANT 55 0.0185
81 TOXIC OPTIC NEUROPATHY 8 0.0184
82 INFECTIVE ANEURYSM 9 0.0182
83 NEPHRITIS INTERSTITIAL 23 0.0182
84 KAPOSI'S SARCOMA 9 0.0179
85 EOSINOPHILIA 287 0.0164
86 AUTOIMMUNE THROMBOCYTOPENIA 7 0.0162
87 SKIN TEST POSITIVE 15 0.0161
88 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 12 0.0156
89 CHORIORETINITIS 10 0.0155
90 PULMONARY EOSINOPHILIA 7 0.0153
91 EOSINOPHILIC MYOCARDITIS 11 0.0151
92 HEPATITIS TOXIC 39 0.0150
93 BONE ABSCESS 6 0.0147
94 GRANULOMA 50 0.0144
95 ARTERITIS 9 0.0142
96 DRUG-INDUCED LIVER INJURY 442 0.0141
97 LYMPHOCYTE STIMULATION TEST POSITIVE 11 0.0137
98 HEPATIC ATROPHY 6 0.0134
99 ACUTE HEPATIC FAILURE 183 0.0134
100 JAUNDICE 360 0.0134
101 HYPERMETABOLISM 7 0.0132
102 DRUG LEVEL DECREASED 133 0.0131
103 PSOAS ABSCESS 8 0.0128
104 MECHANICAL URTICARIA 6 0.0128
105 ACINETOBACTER INFECTION 14 0.0128
106 ENDOCARDITIS BACTERIAL 10 0.0127
107 PULMONARY CAVITATION 11 0.0126
108 AXONAL NEUROPATHY 11 0.0126
109 VASCULITIS NECROTISING 9 0.0126
110 GLOMERULONEPHRITIS MINIMAL LESION 9 0.0124
111 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 11 0.0124
112 ENANTHEMA 7 0.0122
113 HEPATIC ENCEPHALOPATHY 112 0.0120
114 HEPATIC NECROSIS 45 0.0119
115 LIVER TRANSPLANT REJECTION 21 0.0117
116 HEPATORENAL FAILURE 7 0.0116
117 DERMATITIS EXFOLIATIVE 58 0.0116
118 PULMONARY GRANULOMA 13 0.0114
119 DRUG LEVEL ABNORMAL 6 0.0113
120 EPIDERMAL NECROSIS 11 0.0113
121 BLOOD IMMUNOGLOBULIN A INCREASED 6 0.0111
122 EOSINOPHIL PERCENTAGE INCREASED 6 0.0111
123 SPUTUM CULTURE POSITIVE 9 0.0111
124 LEUKOCYTOCLASTIC VASCULITIS 18 0.0111
125 OCULAR TOXICITY 12 0.0109
126 SCOTOMA 8 0.0108
127 ENDOCARDITIS 55 0.0107
128 BRAIN ABSCESS 27 0.0107
129 PATHOGEN RESISTANCE 97 0.0106
130 EMBOLIC CEREBRAL INFARCTION 7 0.0106
131 DRUG RESISTANCE 268 0.0104
132 ACUTE LEFT VENTRICULAR FAILURE 7 0.0104
133 HEPATOTOXICITY 230 0.0103
134 OTOTOXICITY 19 0.0103
135 HEPATOSPLENOMEGALY 26 0.0101
136 RASH MORBILLIFORM 28 0.0101
137 MULTIPLE-DRUG RESISTANCE 31 0.0100
138 PURPURA 88 0.0099
139 HYPOVITAMINOSIS 13 0.0098
140 COLOUR BLINDNESS 9 0.0098
141 PROTHROMBIN LEVEL DECREASED 9 0.0096
142 BACILLUS INFECTION 6 0.0095
143 SERRATIA INFECTION 7 0.0094
144 SUPERINFECTION 14 0.0093
145 OPTIC ATROPHY 15 0.0092
146 RASH MACULO-PAPULAR 204 0.0092
147 BILIRUBIN CONJUGATED INCREASED 21 0.0090
148 CATHETER RELATED INFECTION 9 0.0089
149 HEPATOCELLULAR DAMAGE 20 0.0089
150 INHIBITORY DRUG INTERACTION 14 0.0088
151 LICHENOID KERATOSIS 20 0.0087
152 COMPUTERISED TOMOGRAM THORAX ABNORMAL 6 0.0087
153 CYTOMEGALOVIRUS CHORIORETINITIS 17 0.0087
154 ADRENOCORTICAL INSUFFICIENCY ACUTE 17 0.0087
155 LYMPHADENITIS 21 0.0087
156 VASCULAR PURPURA 12 0.0086
157 SPLENIC INFARCTION 15 0.0086
158 HEPATITIS 219 0.0086
159 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 13 0.0085
160 VIROLOGIC FAILURE 45 0.0084
161 CHYLOTHORAX 6 0.0083
162 HEPATITIS CHOLESTATIC 50 0.0083
163 PNEUMONIA LEGIONELLA 13 0.0081
164 RENAL ATROPHY 10 0.0080
165 MENINGITIS CRYPTOCOCCAL 14 0.0080
166 HYPERSENSITIVITY VASCULITIS 21 0.0080
167 HEART SOUNDS ABNORMAL 6 0.0080
168 MUCOSAL ULCERATION 8 0.0079
169 HYPERLEUKOCYTOSIS 7 0.0079
170 TOXIC SKIN ERUPTION 78 0.0077
171 MENINGITIS BACTERIAL 11 0.0077
172 PRODUCT MONITORING ERROR 11 0.0076
173 PRURIGO 7 0.0076
174 CHOLESTASIS 146 0.0076
175 EXFOLIATIVE RASH 20 0.0076
176 LYMPHADENOPATHY MEDIASTINAL 14 0.0073
177 CACHEXIA 37 0.0072
178 VANISHING BILE DUCT SYNDROME 8 0.0072
179 HYDROCEPHALUS 39 0.0072
180 HYPERURICAEMIA 29 0.0070
181 PO2 DECREASED 8 0.0070
182 HYPERBILIRUBINAEMIA 72 0.0069
183 HUMAN HERPESVIRUS 6 INFECTION 13 0.0069
184 PROTHROMBIN TIME PROLONGED 41 0.0068
185 HILAR LYMPHADENOPATHY 6 0.0068
186 LUNG CONSOLIDATION 19 0.0068
187 BONE MARROW TOXICITY 8 0.0068
188 THERAPEUTIC PRODUCT CROSS-REACTIVITY 6 0.0067
189 OCULAR ICTERUS 29 0.0067
190 NOCARDIOSIS 17 0.0066
191 BLOOD IMMUNOGLOBULIN G INCREASED 8 0.0066
192 HEPATOCELLULAR INJURY 93 0.0066
193 EXTENSOR PLANTAR RESPONSE 6 0.0065
194 HEPATIC FAILURE 195 0.0065
195 GAZE PALSY 11 0.0065
196 PROTHROMBIN TIME SHORTENED 9 0.0064
197 AUTOIMMUNE HAEMOLYTIC ANAEMIA 22 0.0064
198 DRUG INTERACTION 1008 0.0063
199 JAUNDICE CHOLESTATIC 22 0.0062
200 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 55 0.0062
201 CROSS SENSITIVITY REACTION 6 0.0062
202 RESPIRATORY ALKALOSIS 10 0.0061
203 HEPATOMEGALY 60 0.0061
204 IMPLANT SITE INFECTION 14 0.0060
205 HAEMOLYTIC ANAEMIA 53 0.0059
206 NEURITIS 9 0.0058
207 BREAST DISCOMFORT 6 0.0058
208 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 29 0.0057
209 LUNG ABSCESS 12 0.0057
210 TRANSAMINASES INCREASED 127 0.0057
211 ALVEOLITIS 8 0.0057
212 AREFLEXIA 15 0.0056
213 BICYTOPENIA 11 0.0056
214 TRANSPLANT DYSFUNCTION 10 0.0056
215 BAND SENSATION 7 0.0055
216 OESOPHAGEAL CANDIDIASIS 22 0.0055
217 EOSINOPHIL COUNT INCREASED 46 0.0055
218 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 13 0.0055
219 OLIGURIA 34 0.0055
220 OPTIC NEURITIS 49 0.0054
221 ARTHRITIS BACTERIAL 22 0.0054
222 BLOOD BICARBONATE DECREASED 10 0.0053
223 TOXIC EPIDERMAL NECROLYSIS 80 0.0053
224 BLOOD PH DECREASED 9 0.0053
225 LYMPHADENOPATHY 183 0.0052
226 CD4 LYMPHOCYTES DECREASED 11 0.0051
227 TRANSPLANT REJECTION 41 0.0051
228 LYMPHOCYTOSIS 11 0.0051
229 NECROSIS 28 0.0050
230 PNEUMOCYSTIS JIROVECII INFECTION 6 0.0050
231 SKIN NECROSIS 26 0.0050
232 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 19 0.0050
233 DRUG ERUPTION 88 0.0050
234 FANCONI SYNDROME 7 0.0049
235 PSEUDOMEMBRANOUS COLITIS 11 0.0049
236 DRUG LEVEL BELOW THERAPEUTIC 27 0.0049
237 SPLENIC RUPTURE 8 0.0049
238 COMPUTERISED TOMOGRAM ABNORMAL 11 0.0049
239 IMMUNE SYSTEM DISORDER 64 0.0049
240 STAPHYLOCOCCAL BACTERAEMIA 21 0.0048
241 HYPERAMMONAEMIA 24 0.0048
242 HYPERTRANSAMINASAEMIA 33 0.0047
243 HEPATORENAL SYNDROME 8 0.0047
244 HISTIOCYTOSIS HAEMATOPHAGIC 14 0.0047
245 INTERNATIONAL NORMALISED RATIO DECREASED 19 0.0047
246 RENAL TUBULAR NECROSIS 46 0.0047
247 NORMOCHROMIC NORMOCYTIC ANAEMIA 14 0.0047
248 RENAL FAILURE ACUTE 196 0.0046
249 GENERALISED OEDEMA 57 0.0046
250 STATUS EPILEPTICUS 52 0.0046
251 DERMATITIS EXFOLIATIVE GENERALISED 16 0.0046
252 BLOOD BILIRUBIN INCREASED 124 0.0046
253 HENOCH-SCHONLEIN PURPURA 10 0.0046
254 PNEUMATOSIS INTESTINALIS 13 0.0046
255 BLOOD ALBUMIN DECREASED 36 0.0045
256 BLOOD ALKALINE PHOSPHATASE INCREASED 112 0.0045
257 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 35 0.0045
258 LIVER FUNCTION TEST ABNORMAL 131 0.0045
259 DISSEMINATED INTRAVASCULAR COAGULATION 62 0.0044
260 OSTEOLYSIS 9 0.0044
261 LIVER TRANSPLANT 16 0.0044
262 COAGULOPATHY 73 0.0044
263 DISINHIBITION 7 0.0043
264 WOUND SECRETION 17 0.0043
265 STEVENS-JOHNSON SYNDROME 96 0.0043
266 ANURIA 37 0.0043
267 LATENT TUBERCULOSIS 9 0.0043
268 INTERVERTEBRAL DISCITIS 8 0.0042
269 CHEST X-RAY ABNORMAL 13 0.0042
270 CANDIDIASIS 17 0.0042
271 VACCINATION FAILURE 7 0.0042
272 HYPERTHERMIA 32 0.0042
273 ENCEPHALOPATHY 102 0.0041
274 FACE OEDEMA 70 0.0041
275 PANCREATIC ENZYMES INCREASED 6 0.0041
276 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
277 HAEMOLYSIS 31 0.0040
278 MIXED LIVER INJURY 12 0.0040
279 C-REACTIVE PROTEIN INCREASED 145 0.0040
280 ERYTHEMA MULTIFORME 37 0.0040
281 DEAFNESS NEUROSENSORY 13 0.0039
282 TUBULOINTERSTITIAL NEPHRITIS 73 0.0039
283 STAPHYLOCOCCAL SEPSIS 19 0.0038
284 BLOOD UREA INCREASED 64 0.0038
285 HEPATIC FUNCTION ABNORMAL 142 0.0038
286 IRIDOCYCLITIS 12 0.0038
287 OPPORTUNISTIC INFECTION 7 0.0038
288 METABOLIC ACIDOSIS 121 0.0038
289 AGRANULOCYTOSIS 70 0.0038
290 KLEBSIELLA INFECTION 19 0.0038
291 BILE DUCT OBSTRUCTION 7 0.0037
292 RENAL TUBULAR ACIDOSIS 8 0.0037
293 METABOLIC ENCEPHALOPATHY 11 0.0037
294 HYPOREFLEXIA 7 0.0036
295 TENOSYNOVITIS 10 0.0036
296 QUADRIPARESIS 6 0.0036
297 PURULENCE 7 0.0036
298 CHOLESTATIC LIVER INJURY 8 0.0036
299 POTENTIATING DRUG INTERACTION 12 0.0036
300 ADENOCARCINOMA 8 0.0036
301 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79 0.0036
302 DRUG LEVEL INCREASED 59 0.0036
303 PAPULE 25 0.0035
304 HEPATITIS ACUTE 23 0.0035
305 MULTI-ORGAN FAILURE 61 0.0035
306 STILLBIRTH 17 0.0035
307 BLOOD AMYLASE INCREASED 6 0.0035
308 NEPHROTIC SYNDROME 24 0.0035
309 APLASIA PURE RED CELL 12 0.0035
310 ALANINE AMINOTRANSFERASE INCREASED 214 0.0035
311 CHOREA 6 0.0035
312 MUCORMYCOSIS 9 0.0035
313 ASPARTATE AMINOTRANSFERASE INCREASED 183 0.0034
314 MENINGITIS 23 0.0034
315 LEUKOCYTOSIS 62 0.0034
316 INTRACRANIAL PRESSURE INCREASED 19 0.0034
317 LIVER ABSCESS 11 0.0034
318 PREMATURE LABOUR 19 0.0034
319 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
320 SUBCUTANEOUS ABSCESS 16 0.0033
321 SPLENOMEGALY 39 0.0033
322 HYPERTENSIVE CRISIS 37 0.0033
323 LYMPHOPENIA 47 0.0033
324 FOETAL DISTRESS SYNDROME 7 0.0033
325 INTERNATIONAL NORMALISED RATIO INCREASED 94 0.0033
326 HIDRADENITIS 30 0.0033
327 SKIN LESION 90 0.0033
328 RALES 19 0.0033
329 PSEUDOMONAS INFECTION 28 0.0033
330 DYSAESTHESIA 10 0.0033
331 ACUTE RESPIRATORY DISTRESS SYNDROME 57 0.0032
332 STAPHYLOCOCCAL INFECTION 106 0.0032
333 SHOCK HAEMORRHAGIC 26 0.0032
334 LUNG INFILTRATION 28 0.0032
335 ALTERED STATE OF CONSCIOUSNESS 68 0.0031
336 HAEMODIALYSIS 26 0.0031
337 HYPOALBUMINAEMIA 24 0.0031
338 ANTINUCLEAR ANTIBODY POSITIVE 10 0.0031
339 AORTIC VALVE INCOMPETENCE 13 0.0031
340 THROMBOSIS IN DEVICE 10 0.0030
341 SKIN ODOUR ABNORMAL 12 0.0030
342 ASPERGILLUS INFECTION 20 0.0030
343 DERMATITIS BULLOUS 22 0.0030
344 GENE MUTATION 6 0.0030
345 ABDOMINAL TENDERNESS 15 0.0030
346 NEPHRITIS 10 0.0030
347 HYPERCAPNIA 9 0.0030
348 HIV INFECTION 9 0.0030
349 HYPERLACTACIDAEMIA 8 0.0030
350 PETECHIAE 31 0.0030
351 ENCEPHALITIS 20 0.0029
352 RENAL TUBULAR DISORDER 8 0.0028
353 HYPERPYREXIA 12 0.0028
354 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 7 0.0028
355 ORGANISING PNEUMONIA 14 0.0028
356 INFLAMMATORY MARKER INCREASED 14 0.0028
357 ARTHRITIS INFECTIVE 13 0.0028
358 OCULOGYRIC CRISIS 6 0.0028
359 SKIN HYPERPIGMENTATION 24 0.0028
360 THROMBOCYTOPENIA 311 0.0028
361 CEREBELLAR SYNDROME 6 0.0027
362 PANCYTOPENIA 153 0.0027
363 THROMBOCYTOSIS 10 0.0027
364 AMYLASE INCREASED 10 0.0027
365 PLEURISY 16 0.0027
366 ENTEROCOCCAL INFECTION 13 0.0027
367 CREPITATIONS 8 0.0027
368 PYREXIA 919 0.0027
369 INTERNATIONAL NORMALISED RATIO ABNORMAL 9 0.0026
370 PANCREATITIS NECROTISING 6 0.0026
371 HYPERREFLEXIA 9 0.0026
372 NEPHROPATHY TOXIC 29 0.0026
373 ORAL CANDIDIASIS 34 0.0026
374 LUNG NEOPLASM 11 0.0026
375 ASCITES 75 0.0025
376 LIVER INJURY 62 0.0025
377 MACULE 7 0.0025
378 MULTIPLE ORGAN DYSFUNCTION SYNDROME 71 0.0025
379 GASTROINTESTINAL OBSTRUCTION 6 0.0025
380 DIABETES INSIPIDUS 6 0.0025
381 LIPASE INCREASED 19 0.0025
382 RASH PUSTULAR 18 0.0025
383 CUTANEOUS VASCULITIS 9 0.0025
384 GENERALISED ERYTHEMA 14 0.0025
385 GLOMERULONEPHRITIS 6 0.0024
386 BRONCHOPULMONARY ASPERGILLOSIS 19 0.0024
387 BACTERAEMIA 29 0.0024
388 PAPILLOEDEMA 11 0.0024
389 TACHYPNOEA 33 0.0024
390 ACUTE PSYCHOSIS 6 0.0024
391 POLYNEUROPATHY 29 0.0024
392 LACTIC ACIDOSIS 78 0.0024
393 PERSECUTORY DELUSION 6 0.0024
394 CHEILITIS 13 0.0024
395 IMMUNE THROMBOCYTOPENIA 11 0.0024
396 LEUKOPENIA 120 0.0024
397 LOW BIRTH WEIGHT BABY 19 0.0024
398 GRAND MAL CONVULSION 22 0.0024
399 TOOTH DISCOLOURATION 7 0.0024
400 OSTEITIS 6 0.0024
401 ACUTE KIDNEY INJURY 362 0.0024
402 ACIDOSIS 18 0.0024
403 RED BLOOD CELL SEDIMENTATION RATE INCREASED 26 0.0023
404 BLOOD CHLORIDE DECREASED 6 0.0023
405 LIVER DISORDER 103 0.0023
406 ACUTE PULMONARY OEDEMA 13 0.0023
407 CARDIAC TAMPONADE 11 0.0023
408 RETINAL DISORDER 6 0.0023
409 PSYCHIATRIC SYMPTOM 17 0.0023
410 KIDNEY TRANSPLANT REJECTION 11 0.0023
411 EMBOLISM 19 0.0023
412 NYSTAGMUS 12 0.0023
413 HAEMORRHAGE SUBCUTANEOUS 8 0.0023
414 NEUTROPENIC SEPSIS 16 0.0022
415 CHROMATURIA 50 0.0022
416 VISUAL FIELD DEFECT 16 0.0022
417 ABDOMINAL RIGIDITY 6 0.0022
418 HEPATIC ENZYME ABNORMAL 11 0.0022
419 CUSHINGOID 7 0.0022
420 SHOCK 50 0.0022
421 ANOREXIA 28 0.0022
422 BLOOD CREATININE INCREASED 141 0.0022
423 MALNUTRITION 24 0.0021
424 SEROTONIN SYNDROME 41 0.0021
425 GLOMERULAR FILTRATION RATE DECREASED 26 0.0021
426 SEPTIC SHOCK 92 0.0021
427 PURULENT DISCHARGE 9 0.0021
428 LUPUS-LIKE SYNDROME 19 0.0021
429 HYPOVOLAEMIC SHOCK 10 0.0021
430 HEPATIC LESION 9 0.0021
431 APHAGIA 10 0.0021
432 RESPIRATORY ACIDOSIS 8 0.0020
433 RESPIRATORY DISTRESS 56 0.0020
434 PLEURAL EFFUSION 123 0.0020
435 MYOCLONUS 24 0.0020
436 AZOTAEMIA 8 0.0020
437 TYPE I HYPERSENSITIVITY 7 0.0020
438 BLOOD CREATINE PHOSPHOKINASE INCREASED 57 0.0020
439 VASCULITIS 23 0.0020
440 TOXIC ENCEPHALOPATHY 10 0.0020
441 DRUG LEVEL ABOVE THERAPEUTIC 9 0.0020
442 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 10 0.0020
443 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
444 PERIPHERAL ISCHAEMIA 8 0.0020
445 PNEUMOTHORAX 31 0.0020
446 PROTEINURIA 37 0.0019
447 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
448 BONE MARROW FAILURE 39 0.0019
449 APLASTIC ANAEMIA 10 0.0019
450 BLOOD LACTIC ACID INCREASED 10 0.0019
451 SKIN PLAQUE 16 0.0019
452 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
453 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
454 JOINT EFFUSION 13 0.0019
455 RASH ERYTHEMATOUS 90 0.0019
456 MIOSIS 15 0.0019
457 SKIN DISORDER 62 0.0019
458 BACTERIAL SEPSIS 6 0.0018
459 TENDON DISORDER 12 0.0018
460 LYMPHOCYTE COUNT INCREASED 6 0.0018
461 DRUG TOXICITY 25 0.0018
462 HEPATIC ENZYME INCREASED 125 0.0018
463 PANCREATITIS ACUTE 41 0.0018
464 BLOOD CREATINE INCREASED 8 0.0018
465 CARDIOPULMONARY FAILURE 7 0.0018
466 TREATMENT FAILURE 148 0.0018
467 CANDIDA INFECTION 30 0.0018
468 SKIN REACTION 25 0.0018
469 RENAL IMPAIRMENT 149 0.0018
470 POLYDIPSIA 7 0.0018
471 AMMONIA INCREASED 9 0.0018
472 DEVICE RELATED INFECTION 27 0.0018
473 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
474 GENERALISED TONIC-CLONIC SEIZURE 29 0.0018
475 HEPATIC FIBROSIS 6 0.0017
476 SEPSIS 195 0.0017
477 BRAIN OEDEMA 22 0.0017
478 MYOPATHY 15 0.0017
479 ENTEROCOLITIS 10 0.0017
480 BLOOD URIC ACID INCREASED 10 0.0017
481 PARTIAL SEIZURES 9 0.0017
482 CATATONIA 9 0.0017
483 SERUM FERRITIN INCREASED 9 0.0017
484 ESCHERICHIA INFECTION 14 0.0017
485 NECROTISING FASCIITIS 6 0.0017
486 INTERSTITIAL LUNG DISEASE 82 0.0017
487 CONJUNCTIVAL HYPERAEMIA 6 0.0017
488 RHABDOMYOLYSIS 70 0.0017
489 BLOOD PRESSURE INADEQUATELY CONTROLLED 10 0.0017
490 OSTEOMYELITIS 30 0.0017
491 HYPONATRAEMIA 93 0.0016
492 HAEMOPTYSIS 46 0.0016
493 HYPOKALAEMIA 76 0.0016
494 DEPRESSED LEVEL OF CONSCIOUSNESS 65 0.0016
495 RESPIRATORY FAILURE 119 0.0016
496 METASTASES TO LYMPH NODES 11 0.0016
497 ECCHYMOSIS 11 0.0016
498 HEMIPARESIS 27 0.0016
499 DERMATITIS ALLERGIC 20 0.0016
500 RASH GENERALISED 41 0.0016
501 ADRENAL INSUFFICIENCY 19 0.0016
502 HEMIPLEGIA 13 0.0016
503 MENINGITIS ASEPTIC 7 0.0016
504 HYPERVENTILATION 9 0.0016
505 DIALYSIS 22 0.0015
506 HYPERKALAEMIA 54 0.0015
507 WHITE BLOOD CELL COUNT INCREASED 59 0.0015
508 HYPERTRIGLYCERIDAEMIA 9 0.0015
509 ATAXIA 18 0.0015
510 CEREBRAL ATROPHY 6 0.0015
511 ABSCESS 24 0.0015
512 YELLOW SKIN 7 0.0015
513 NEUROTOXICITY 26 0.0015
514 LUNG INFECTION 23 0.0015
515 UVEITIS 20 0.0015
516 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
517 POLYURIA 12 0.0015
518 HYPERAESTHESIA 12 0.0015
519 HYPERCALCAEMIA 18 0.0015
520 PIGMENTATION DISORDER 9 0.0015
521 CHOLANGITIS 9 0.0015
522 DELIRIUM 50 0.0014
523 CONGESTIVE CARDIOMYOPATHY 6 0.0014
524 PNEUMONITIS 39 0.0014
525 PREMATURE BABY 43 0.0014
526 TENDONITIS 22 0.0014
527 BREATH SOUNDS ABNORMAL 7 0.0014
528 LIP OEDEMA 6 0.0014
529 MUSCLE FATIGUE 6 0.0014
530 RENAL FAILURE 187 0.0014
531 ABSCESS LIMB 6 0.0014
532 ACUTE RESPIRATORY FAILURE 27 0.0014
533 HERPES VIRUS INFECTION 8 0.0014
534 PERICARDIAL EFFUSION 32 0.0014
535 CYTOMEGALOVIRUS INFECTION 23 0.0014
536 HEPATIC CIRRHOSIS 26 0.0014
537 BRADYPHRENIA 9 0.0014
538 NEUTROPENIA 187 0.0014
539 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
540 FAILURE TO THRIVE 7 0.0013
541 SKIN MASS 9 0.0013
542 ILEUS PARALYTIC 6 0.0013
543 ENDOPHTHALMITIS 8 0.0013
544 HEPATITIS B 8 0.0013
545 REBOUND EFFECT 15 0.0013
546 CARDIOGENIC SHOCK 19 0.0013
547 CEREBRAL INFARCTION 32 0.0013
548 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
549 RENAL FAILURE CHRONIC 10 0.0013
550 LARYNGEAL OEDEMA 8 0.0013
551 PNEUMOCYSTIS JIROVECII PNEUMONIA 13 0.0013
552 SKIN ABRASION 6 0.0013
553 HYPOCALCAEMIA 24 0.0013
554 HAEMATOCRIT DECREASED 25 0.0013
555 CONVULSION 72 0.0013
556 HYPOXIA 44 0.0012
557 ATELECTASIS 12 0.0012
558 DERMATITIS 26 0.0012
559 INFLAMMATION 64 0.0012
560 SUDDEN DEATH 13 0.0012
561 MELAENA 27 0.0012
562 PROTEIN URINE PRESENT 6 0.0012
563 CARDIAC FAILURE ACUTE 8 0.0012
564 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
565 PNEUMONIA BACTERIAL 11 0.0012
566 HAEMATURIA 41 0.0012
567 HYPOVOLAEMIA 7 0.0012
568 EMPHYSEMA 12 0.0012
569 HAEMODYNAMIC INSTABILITY 9 0.0012
570 NEPHROPATHY 11 0.0012
571 FEMORAL NECK FRACTURE 6 0.0012
572 ANAEMIA 223 0.0012
573 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
574 CEREBRAL ISCHAEMIA 6 0.0012
575 FOETAL GROWTH RESTRICTION 7 0.0012
576 NODULE 15 0.0011
577 VISUAL ACUITY REDUCED 38 0.0011
578 CONDITION AGGRAVATED 347 0.0011
579 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
580 IMMUNOSUPPRESSION 10 0.0011
581 BODY TEMPERATURE INCREASED 23 0.0011
582 ILEUS 14 0.0011
583 RESPIRATORY RATE INCREASED 10 0.0011
584 TACHYCARDIA 100 0.0011
585 GENERAL PHYSICAL HEALTH DETERIORATION 130 0.0011
586 SENSORY DISTURBANCE 18 0.0011
587 SENSORY LOSS 9 0.0011
588 PARALYSIS 16 0.0011
589 PSYCHOTIC DISORDER 33 0.0011
590 HYPOGLYCAEMIA 54 0.0011
591 EPILEPSY 34 0.0011
592 PRURITUS GENERALISED 24 0.0011
593 THERAPEUTIC RESPONSE CHANGED 7 0.0011
594 NORMAL NEWBORN 6 0.0011
595 PALLOR 30 0.0011
596 PREGNANCY 22 0.0011
597 PULMONARY FIBROSIS 21 0.0011
598 ENTERITIS 7 0.0011
599 OEDEMA 59 0.0011
600 STREPTOCOCCAL INFECTION 6 0.0011
601 COORDINATION ABNORMAL 15 0.0011
602 NEUTROPHIL COUNT INCREASED 11 0.0011
603 PERICARDITIS 18 0.0011
604 RASH PRURITIC 58 0.0011
605 NO THERAPEUTIC RESPONSE 13 0.0011
606 DYSARTHRIA 40 0.0011
607 BLINDNESS 43 0.0011
608 GRANULOCYTOPENIA 6 0.0011
609 TROPONIN INCREASED 8 0.0011
610 BLISTER 59 0.0010
611 COMA 50 0.0010
612 UNRESPONSIVE TO STIMULI 27 0.0010
613 RESTLESSNESS 38 0.0010
614 SKIN WARM 6 0.0010
615 RASH PAPULAR 23 0.0010
616 VITAMIN D DEFICIENCY 10 0.0010
617 ANAPHYLACTIC SHOCK 26 0.0010
618 PULMONARY MASS 15 0.0010
619 AUTOIMMUNE HEPATITIS 7 0.0010
620 ODYNOPHAGIA 6 0.0010
621 HYPOTONIA 10 0.0010
622 BLOOD DISORDER 8 0.0010
623 BRONCHOSPASM 14 0.0010
624 ELECTROCARDIOGRAM QT PROLONGED 35 0.0010
625 CONFUSIONAL STATE 157 0.0010
626 DEEP VEIN THROMBOSIS 63 0.0010
627 NEUROPATHY PERIPHERAL 92 0.0010
628 SKIN ULCER 25 0.0010
629 PERITONITIS 20 0.0010
630 BACTERIAL INFECTION 18 0.0010
631 NIGHT SWEATS 31 0.0010
632 VOMITING 452 0.0010
633 PNEUMONIA ASPIRATION 24 0.0010
634 PULMONARY OEDEMA 43 0.0010
635 DEAFNESS 25 0.0010
636 MOUTH HAEMORRHAGE 7 0.0010
637 HAEMOGLOBIN DECREASED 98 0.0010
638 CYANOSIS 15 0.0010
639 OEDEMA PERIPHERAL 116 0.0010
640 EYELID OEDEMA 11 0.0009
641 VITAMIN D DECREASED 8 0.0009
642 MYDRIASIS 12 0.0009
643 ANGIOEDEMA 41 0.0009
644 DISEASE RECURRENCE 44 0.0009
645 AUTOIMMUNE DISORDER 9 0.0009
646 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
647 DISORIENTATION 36 0.0009
648 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
649 PULMONARY HAEMORRHAGE 7 0.0009
650 TENDON RUPTURE 11 0.0009
651 FISTULA 10 0.0009
652 RECTAL HAEMORRHAGE 38 0.0009
653 TRICUSPID VALVE INCOMPETENCE 7 0.0009
654 SCAR 15 0.0009
655 VENTRICULAR EXTRASYSTOLES 9 0.0009
656 NERVOUS SYSTEM DISORDER 27 0.0009
657 CONJUNCTIVITIS 16 0.0009
658 BLOOD SODIUM DECREASED 16 0.0008
659 CARDIAC ARREST 70 0.0008
660 RESPIRATORY TRACT INFECTION 22 0.0008
661 ANKYLOSING SPONDYLITIS 11 0.0008
662 FAECES SOFT 6 0.0008
663 TREATMENT NONCOMPLIANCE 45 0.0008
664 HYPOPHAGIA 21 0.0008
665 PRODUCTIVE COUGH 39 0.0008
666 PLATELET COUNT DECREASED 87 0.0008
667 CARDIOMYOPATHY 12 0.0008
668 RED BLOOD CELL COUNT DECREASED 23 0.0008
669 INTESTINAL PERFORATION 9 0.0008
670 PERIPHERAL COLDNESS 11 0.0008
671 URINE OUTPUT DECREASED 7 0.0008
672 BLOOD POTASSIUM INCREASED 13 0.0008
673 TUMOUR LYSIS SYNDROME 7 0.0008
674 MITRAL VALVE INCOMPETENCE 9 0.0008
675 MENTAL STATUS CHANGES 22 0.0008
676 MUSCLE ATROPHY 10 0.0008
677 HEPATIC CYTOLYSIS 10 0.0008
678 PANCREATITIS 41 0.0008
679 ELECTROLYTE IMBALANCE 9 0.0008
680 APNOEA 6 0.0008
681 PLATELET COUNT INCREASED 10 0.0008
682 CIRCULATORY COLLAPSE 13 0.0008
683 RETINAL DETACHMENT 7 0.0008
684 SKIN EXFOLIATION 64 0.0008
685 GASTROENTERITIS 11 0.0008
686 PREMATURE DELIVERY 12 0.0008
687 HYPOTHYROIDISM 24 0.0008
688 RHINITIS 6 0.0007
689 RASH MACULAR 26 0.0007
690 ERYTHEMA 152 0.0007
691 HAEMATOTOXICITY 7 0.0007
692 DECUBITUS ULCER 6 0.0007
693 ABDOMINAL PAIN 171 0.0007
694 THERAPY NON-RESPONDER 33 0.0007
695 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
696 DIPLOPIA 19 0.0007
697 WOUND INFECTION 8 0.0007
698 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
699 AFFECT LABILITY 7 0.0007
700 DISEASE PROGRESSION 86 0.0007
701 FOETAL EXPOSURE DURING PREGNANCY 59 0.0007
702 TOXICITY TO VARIOUS AGENTS 122 0.0007
703 CARDIAC FAILURE 58 0.0007
704 VENTRICULAR FIBRILLATION 8 0.0007
705 CARDIO-RESPIRATORY ARREST 30 0.0007
706 HALLUCINATION, VISUAL 15 0.0007
707 SCAB 8 0.0007
708 LIVER FUNCTION TEST INCREASED 15 0.0007
709 MYOCARDITIS 8 0.0007
710 CARDIAC MURMUR 6 0.0007
711 RASH 302 0.0007
712 PYELONEPHRITIS 6 0.0007
713 HYPOTHERMIA 7 0.0007
714 ECZEMA 36 0.0007
715 HYPOTENSION 138 0.0007
716 GROIN PAIN 6 0.0007
717 METASTASES TO LIVER 12 0.0007
718 DECREASED APPETITE 158 0.0007
719 SOPOR 9 0.0007
720 BRADYCARDIA 36 0.0007
721 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
722 LUNG DISORDER 33 0.0007
723 TENDERNESS 7 0.0007
724 CHOLECYSTITIS 8 0.0007
725 VENTRICULAR TACHYCARDIA 11 0.0007
726 PHOTOSENSITIVITY REACTION 11 0.0007
727 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
728 PRURITUS 254 0.0007
729 EXPOSURE DURING PREGNANCY 41 0.0007
730 BURSITIS 8 0.0007
731 GINGIVAL BLEEDING 9 0.0007
732 GASTROINTESTINAL HAEMORRHAGE 55 0.0007
733 NEURALGIA 16 0.0007
734 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
735 CARDIOMEGALY 8 0.0006
736 DRUG EXPOSURE DURING PREGNANCY 22 0.0006
737 EJECTION FRACTION DECREASED 10 0.0006
738 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 35 0.0006
739 ABORTION INDUCED 6 0.0006
740 SINUS TACHYCARDIA 9 0.0006
741 SEIZURE 73 0.0006
742 CHILLS 74 0.0006
743 ULCER 10 0.0006
744 LYMPHOCYTE COUNT DECREASED 11 0.0006
745 MENTAL DISORDER 27 0.0006
746 MOUTH ULCERATION 13 0.0006
747 WHITE BLOOD CELL COUNT DECREASED 66 0.0006
748 OXYGEN SATURATION DECREASED 34 0.0006
749 HAEMORRHAGE INTRACRANIAL 9 0.0006
750 PULMONARY EMBOLISM 57 0.0006
751 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
752 HEPATIC STEATOSIS 11 0.0006
753 EYELID PTOSIS 6 0.0006
754 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
755 SUBARACHNOID HAEMORRHAGE 6 0.0006
756 PRODUCT USE IN UNAPPROVED INDICATION 144 0.0006
757 ACUTE MYOCARDIAL INFARCTION 17 0.0006
758 MUCOSAL INFLAMMATION 15 0.0006
759 BLOOD PRESSURE DECREASED 38 0.0006
760 HALLUCINATION 43 0.0006
761 NEUTROPHIL COUNT DECREASED 23 0.0006
762 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
763 OESOPHAGITIS 6 0.0005
764 AGITATION 40 0.0005
765 GASTROINTESTINAL DISORDER 48 0.0005
766 PNEUMONIA 173 0.0005
767 CEREBRAL HAEMORRHAGE 19 0.0005
768 PULMONARY HYPERTENSION 11 0.0005
769 DRUG INTOLERANCE 51 0.0005
770 HYPERSENSITIVITY 97 0.0005
771 HIP ARTHROPLASTY 8 0.0005
772 IMPAIRED GASTRIC EMPTYING 7 0.0005
773 THERAPY PARTIAL RESPONDER 8 0.0005
774 FAECES DISCOLOURED 11 0.0005
775 NAUSEA 394 0.0005
776 SEASONAL ALLERGY 7 0.0005
777 MATERNAL EXPOSURE DURING PREGNANCY 44 0.0005
778 URTICARIA 82 0.0005
779 FLUID OVERLOAD 7 0.0005
780 MALAISE 209 0.0005
781 COLITIS 18 0.0005
782 HYPERHIDROSIS 61 0.0005
783 HAEMATEMESIS 12 0.0005
784 DYSPNOEA 267 0.0005
785 ASTHENIA 177 0.0005
786 ANAPHYLACTIC REACTION 26 0.0005
787 IMMUNODEFICIENCY 7 0.0005
788 FEBRILE NEUTROPENIA 31 0.0005
789 DRUG EFFECT DECREASED 25 0.0005
790 HYPERTENSION 98 0.0005
791 CHOLELITHIASIS 15 0.0005
792 MYALGIA 77 0.0005
793 LOSS OF CONSCIOUSNESS 58 0.0005
794 SOMNOLENCE 91 0.0005
795 PAIN OF SKIN 12 0.0004
796 THERAPEUTIC RESPONSE DECREASED 27 0.0004
797 SYNOVITIS 8 0.0004
798 HYPOACUSIS 19 0.0004
799 WEIGHT DECREASED 122 0.0004
800 LETHARGY 25 0.0004
801 IRRITABILITY 26 0.0004
802 HYPOMAGNESAEMIA 6 0.0004
803 RETCHING 9 0.0004
804 COUGH 118 0.0004
805 VIRAL INFECTION 14 0.0004
806 GASTRITIS 11 0.0004
807 CELLULITIS 21 0.0004
808 POST PROCEDURAL COMPLICATION 8 0.0004
809 ANOSMIA 6 0.0004
810 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
811 PRESCRIBED OVERDOSE 8 0.0004
812 DEHYDRATION 55 0.0004
813 CHEST PAIN 76 0.0004
814 URINARY INCONTINENCE 12 0.0004
815 VISUAL IMPAIRMENT 50 0.0004
816 ABDOMINAL DISTENSION 42 0.0004
817 OSTEONECROSIS 13 0.0004
818 HEART RATE INCREASED 39 0.0004
819 DRUG INEFFECTIVE 518 0.0004
820 ATRIAL FIBRILLATION 38 0.0004
821 URINARY RETENTION 13 0.0004
822 HYPERGLYCAEMIA 14 0.0004
823 DYSURIA 14 0.0004
824 SYNCOPE 38 0.0004
825 STOMATITIS 23 0.0004
826 HALLUCINATION, AUDITORY 6 0.0004
827 VERTIGO 23 0.0004
828 INTESTINAL OBSTRUCTION 14 0.0004
829 PRESYNCOPE 9 0.0004
830 MUSCULAR WEAKNESS 42 0.0004
831 ABDOMINAL PAIN UPPER 76 0.0004
832 DIABETES MELLITUS 28 0.0004
833 BLOOD POTASSIUM DECREASED 11 0.0004
834 MANIA 6 0.0004
835 DRUG PRESCRIBING ERROR 7 0.0004
836 RESPIRATORY ARREST 10 0.0004
837 AGEUSIA 9 0.0004
838 ARRHYTHMIA 17 0.0004
839 TREMOR 59 0.0004
840 HEART RATE IRREGULAR 8 0.0004
841 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
842 FEEDING DISORDER 7 0.0003
843 NEOPLASM PROGRESSION 12 0.0003
844 MUSCULOSKELETAL PAIN 18 0.0003
845 RENAL DISORDER 16 0.0003
846 MOVEMENT DISORDER 11 0.0003
847 HEART RATE DECREASED 12 0.0003
848 INFECTION 49 0.0003
849 FEAR 9 0.0003
850 GOUT 6 0.0003
851 DIARRHOEA 214 0.0003
852 INFLUENZA LIKE ILLNESS 27 0.0003
853 HYPOAESTHESIA 49 0.0003
854 TINNITUS 15 0.0003
855 SKIN DISCOLOURATION 15 0.0003
856 JOINT SWELLING 39 0.0003
857 EPISTAXIS 24 0.0003
858 WHEEZING 19 0.0003
859 DYSPNOEA EXERTIONAL 12 0.0003
860 FRACTURE 6 0.0003
861 SUICIDAL IDEATION 29 0.0003
862 GASTRIC ULCER 6 0.0003
863 HAEMORRHAGE 33 0.0003
864 ARTHRALGIA 130 0.0003
865 HAEMATOMA 8 0.0003
866 HAEMATOCHEZIA 17 0.0003
867 MOBILITY DECREASED 22 0.0003
868 MEDICATION ERROR 17 0.0003
869 SPEECH DISORDER 16 0.0003
870 NEPHROLITHIASIS 14 0.0003
871 ABNORMAL BEHAVIOUR 12 0.0003
872 DEPRESSED MOOD 16 0.0003
873 RESPIRATORY DISORDER 9 0.0003
874 ABORTION SPONTANEOUS 12 0.0003
875 BURNING SENSATION 21 0.0003
876 APHASIA 9 0.0003
877 DYSKINESIA 12 0.0003
878 OVERDOSE 63 0.0003
879 VISION BLURRED 40 0.0003
880 HEADACHE 182 0.0003
881 OFF LABEL USE 253 0.0003
882 MENTAL IMPAIRMENT 7 0.0003
883 DYSPHAGIA 27 0.0003
884 COGNITIVE DISORDER 13 0.0003
885 ABDOMINAL PAIN LOWER 7 0.0003
886 SWELLING FACE 18 0.0003
887 PANIC ATTACK 10 0.0003
888 MUSCULOSKELETAL STIFFNESS 24 0.0003
889 LIP SWELLING 9 0.0003
890 DYSGEUSIA 20 0.0003
891 ARTHRITIS 21 0.0003
892 EYE PAIN 15 0.0003
893 DISTURBANCE IN ATTENTION 14 0.0003
894 LIMB DISCOMFORT 8 0.0003
895 CYSTITIS 8 0.0003
896 DIABETIC KETOACIDOSIS 6 0.0002
897 PARAESTHESIA 39 0.0002
898 THROAT IRRITATION 11 0.0002
899 DYSPEPSIA 24 0.0002
900 CATARACT 14 0.0002
901 SWELLING 22 0.0002
902 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
903 NIGHTMARE 8 0.0002
904 SEDATION 6 0.0002
905 FEELING HOT 14 0.0002
906 DYSPHONIA 13 0.0002
907 AGGRESSION 11 0.0002
908 BACK PAIN 51 0.0002
909 FLUSHING 22 0.0002
910 DEATH 186 0.0002
911 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
912 EYE DISORDER 7 0.0002
913 DIZZINESS 106 0.0002
914 ADVERSE DRUG REACTION 19 0.0002
915 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
916 ANGINA PECTORIS 6 0.0002
917 BLOOD PRESSURE INCREASED 32 0.0002
918 PAIN 128 0.0002
919 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
920 PAIN IN EXTREMITY 61 0.0002
921 GASTRIC DISORDER 7 0.0002
922 RENAL INJURY 6 0.0002
923 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
924 URINARY TRACT INFECTION 34 0.0002
925 INFUSION RELATED REACTION 13 0.0002
926 DRUG ADMINISTRATION ERROR 6 0.0002
927 CHEST DISCOMFORT 20 0.0002
928 DRUG EFFECT INCOMPLETE 7 0.0002
929 HERPES ZOSTER 11 0.0002
930 WITHDRAWAL SYNDROME 8 0.0002
931 FATIGUE 147 0.0002
932 OSTEOARTHRITIS 8 0.0002
933 GAIT DISTURBANCE 36 0.0002
934 AMNESIA 12 0.0002
935 SLEEP DISORDER 13 0.0002
936 PALPITATIONS 21 0.0002
937 COLITIS ULCERATIVE 8 0.0002
938 ABDOMINAL DISCOMFORT 30 0.0002
939 CARDIAC FAILURE CONGESTIVE 14 0.0002
940 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
941 PSORIATIC ARTHROPATHY 7 0.0002
942 INTENTIONAL OVERDOSE 11 0.0002
943 LUNG NEOPLASM MALIGNANT 7 0.0002
944 INSOMNIA 45 0.0002
945 MYELOSUPPRESSION 6 0.0002
946 PRODUCT USE ISSUE 31 0.0002
947 SUICIDE ATTEMPT 10 0.0002
948 ACCIDENTAL OVERDOSE 6 0.0002
949 DISCOMFORT 10 0.0002
950 DEPRESSION 37 0.0002
951 BALANCE DISORDER 14 0.0002
952 CHRONIC KIDNEY DISEASE 12 0.0002
953 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
954 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
955 CONTUSION 14 0.0001
956 WEIGHT INCREASED 32 0.0001
957 OROPHARYNGEAL PAIN 13 0.0001
958 ANXIETY 39 0.0001
959 PERIPHERAL SWELLING 20 0.0001
960 RHEUMATOID ARTHRITIS 14 0.0001
961 ADVERSE EVENT 11 0.0001
962 PSORIASIS 15 0.0001
963 MYOCARDIAL INFARCTION 20 0.0001
964 THROMBOSIS 9 0.0001
965 DRY MOUTH 9 0.0001
966 DRUG ABUSE 9 0.0001
967 NECK PAIN 6 0.0001
968 ASTHMA 12 0.0001
969 HOT FLUSH 8 0.0001
970 BLOOD GLUCOSE INCREASED 20 0.0001
971 FLATULENCE 6 0.0001
972 FALL 35 0.0001
973 INJURY 7 0.0001
974 ILL-DEFINED DISORDER 6 0.0001
975 SKIN BURNING SENSATION 7 0.0001
976 SINUSITIS 10 0.0001
977 MIGRAINE 9 0.0001
978 RHINORRHOEA 6 0.0001
979 CONSTIPATION 20 0.0001
980 DRUG WITHDRAWAL SYNDROME 8 0.0001
981 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
982 ALOPECIA 17 0.0001
983 CEREBROVASCULAR ACCIDENT 14 0.0001
984 INTENTIONAL PRODUCT MISUSE 7 0.0001
985 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
986 MEMORY IMPAIRMENT 10 0.0001
987 INFLUENZA 8 0.0001
988 MUSCLE SPASMS 13 0.0001
989 DRY SKIN 9 0.0001
990 CARDIAC DISORDER 6 0.0001
991 INJECTION SITE PAIN 17 0.0001
992 FEELING ABNORMAL 13 0.0001
993 INCORRECT DOSE ADMINISTERED 12 0.0001
994 HOSPITALISATION 8 0.0001
995 NO ADVERSE EVENT 8 0.0000
996 DRUG DEPENDENCE 6 0.0000